These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7026871)

  • 1. Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy.
    Miller T; Phillips S
    Kidney Int; 1981 May; 19(5):654-62. PubMed ID: 7026871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scarring as a factor affecting the eradication of microorganisms from the kidney in pyelonephritis.
    Miller T
    Antimicrob Agents Chemother; 1983 Mar; 23(3):500-2. PubMed ID: 6601931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental pyelonephritis: the effect of chronic active pyelonephritis on renal function.
    Miller TE; Layzell D; Stewart E
    Kidney Int; 1976 Jan; 9(1):23-9. PubMed ID: 781379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis.
    Yagmurlu A; Boleken ME; Ertoy D; Ozsan M; Gokcora IH; Dindar H
    Urology; 2003 May; 61(5):1037-41. PubMed ID: 12736043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the chemotherapeutic effectiveness of mecillinam, ampicillin and their combination in coli bacillary pyelonephritis in rats].
    Zinchenko TA; Starkov MV; Rudzit EA; Lisitsa LI
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):40-3. PubMed ID: 3511839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial agents in the management of urinary tract infection: an experimental evaluation.
    Lecamwasam JP; Miller TE
    J Lab Clin Med; 1989 Nov; 114(5):510-9. PubMed ID: 2681480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis.
    Bergeron MG; Marois Y
    Kidney Int; 1986 Oct; 30(4):481-7. PubMed ID: 3537452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy.
    Slotki IN; Asscher AW
    Nephron; 1982; 30(3):262-8. PubMed ID: 7099339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ampicillin efficacy by peroral levodopa in rat pyelonephritis.
    Burrous SE; Siedler AJ; Eudy WW
    Life Sci II; 1972 Nov; 11(22):1087-93. PubMed ID: 4197568
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary concentrating ability in early experimental pyelonephritis.
    Kaye D; Rocha H
    J Clin Invest; 1970 Jul; 49(7):1427-37. PubMed ID: 4914680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathobiology of subclinical pyelonephritis--an experimental evaluation.
    Miller TE; Findon G; Rainer SP; Gavin JB
    Kidney Int; 1992 May; 41(5):1356-65. PubMed ID: 1614050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental therapy of colibacillary pyelonephritis in rats].
    Lisitsa LI; Rudzit EA
    Farmakol Toksikol; 1972; 35(2):229-32. PubMed ID: 4553769
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergism of ampicillin and gentamicin against obstructive pyelonephritis due to Escherichia coli in rats.
    Glauser MP; Lyons JM; Braude AI
    J Infect Dis; 1979 Feb; 139(2):133-40. PubMed ID: 374640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of methylene blue on renal scarring due to pyelonephritis in rats.
    Aksu B; Inan M; Kanter M; Oz Puyan F; Uzun H; Durmus-Altun G; Gurcan S; Aydin S; Ayvaz S; Pul M
    Pediatr Nephrol; 2007 Jul; 22(7):992-1001. PubMed ID: 17390153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis.
    Olson PD; McLellan LK; Liu A; Briden KE; Tiemann KM; Daugherty AL; Hruska KA; Hunstad DA
    Dis Model Mech; 2017 Nov; 10(11):1371-1379. PubMed ID: 28882930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of 5,2'-dibromo-2,4',5'-trihydroxydiphenylmethanone (LM49) in an experimental rat model of acute pyelonephritis by immunomodulation and anti-inflammation.
    Zhang YL; Feng XE; Chang RR; Zhang LH; Xiao BG; Li QS; Hao XL
    Int Immunopharmacol; 2018 Sep; 62():155-164. PubMed ID: 30007245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis.
    Bahat Özdoğan E; Özdemir T; Arslansoyu Çamlar S; Imamoğlu M; Cobanoğlu Ü; Sönmez B; Tosun İ; Doğan I
    Biomed Res Int; 2014; 2014():134940. PubMed ID: 25105116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
    Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of iron on acute pyelonephritis and later chronic changes.
    Guze LB; Guze PA; Kalmanson GM; Glassock RJ
    Kidney Int; 1982 Jun; 21(6):808-12. PubMed ID: 6752529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
    Rudzit EA; Lisitsa LI
    Farmakol Toksikol; 1971; 34(2):246-50. PubMed ID: 4998195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.